Abstract
A number of studies have demonstrated a role for transition metals and oxidative stress in the etiology of Parkinson ’ s disease (PD). Genetic and biochemical evidence also clearly links the protein alpha-synuclein (αSyn) to PD and a number of associated diseases. In these “synucleinopathies”, αSyn is deposited, often in oligomerized forms, as cytoplasmic inclusions known as Lewy bodies and Lewy neurites. αSyn cross-linking/oligomerization can occur via a number of processes, most stimulated by metal catalyzed oxidation (MCO). In PD, the increased sensitivity of midbrain neurons expressing high levels of oxidizable catecholamines may provide one clue to account for degeneration of these neurons. In other regions of the nervous system that develop Lewy body pathology, the mode of αSyn oligomerization is less clear. Thus, the relationship between αSyn and MCO, either direct or indirect, represents a particular concern for possible treatment of these various diseases.
Keywords: Parkinson's disease, alpha-synuclein, metals, oxidation, dopamine, oligomerization, cross-linking, neuromelanin
Current Alzheimer Research
Title: Metal Catalyzed Oxidation of Alpha-Synuclein – A Role for Oligomerization in Pathology?
Volume: 5 Issue: 6
Author(s): N. B. Cole
Affiliation:
Keywords: Parkinson's disease, alpha-synuclein, metals, oxidation, dopamine, oligomerization, cross-linking, neuromelanin
Abstract: A number of studies have demonstrated a role for transition metals and oxidative stress in the etiology of Parkinson ’ s disease (PD). Genetic and biochemical evidence also clearly links the protein alpha-synuclein (αSyn) to PD and a number of associated diseases. In these “synucleinopathies”, αSyn is deposited, often in oligomerized forms, as cytoplasmic inclusions known as Lewy bodies and Lewy neurites. αSyn cross-linking/oligomerization can occur via a number of processes, most stimulated by metal catalyzed oxidation (MCO). In PD, the increased sensitivity of midbrain neurons expressing high levels of oxidizable catecholamines may provide one clue to account for degeneration of these neurons. In other regions of the nervous system that develop Lewy body pathology, the mode of αSyn oligomerization is less clear. Thus, the relationship between αSyn and MCO, either direct or indirect, represents a particular concern for possible treatment of these various diseases.
Export Options
About this article
Cite this article as:
Cole B. N., Metal Catalyzed Oxidation of Alpha-Synuclein – A Role for Oligomerization in Pathology?, Current Alzheimer Research 2008; 5 (6) . https://dx.doi.org/10.2174/156720508786898523
DOI https://dx.doi.org/10.2174/156720508786898523 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Berberine: A Plant-derived Alkaloid with Therapeutic Potential to Combat Alzheimer’s disease
Central Nervous System Agents in Medicinal Chemistry MicroRNAs in Breast Cancer: One More Turn in Regulation
Current Drug Targets Nongenomic Actions of Thyroid Hormones: From Basic Research to Clinical Applications. An Update
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Confocal Microscopy Evidence of Prion Protein Fragment hPrP[173-195] Internalization in Rat B104 Neuroblastoma Cell Line
Protein & Peptide Letters Therapeutic Targeting of Malignant Glioma
Anti-Cancer Agents in Medicinal Chemistry Current Trends in Virtual High Throughput Screening Using Ligand-Based and Structure-Based Methods
Combinatorial Chemistry & High Throughput Screening Ras Family Small GTPase-Mediated Neuroprotective Signaling in Stroke
Central Nervous System Agents in Medicinal Chemistry Radionuclide Antibody-Conjugates, a Targeted Therapy Towards Cancer
Current Radiopharmaceuticals Targeting the G2/M Transition for Antitumor Therapy
Letters in Drug Design & Discovery Protein Kinase CK2 in Human Diseases
Current Medicinal Chemistry Nephrotoxicity of Bisphenol A (BPA) -An Updated Review
Current Molecular Pharmacology Recent Advances in the Design and Development of Anticancer Molecules based on PROTAC Technology
Current Medicinal Chemistry Epi-Drugs and Epi-miRs: Moving Beyond Current Cancer Therapies
Current Cancer Drug Targets MDM2-p53 Interaction in Paediatric Solid Tumours: Preclinical Rationale, Biomarkers and Resistance
Current Drug Targets Ubiquitylation and Cancer Development
Current Cancer Drug Targets Common Pathways in Health Benefit Properties of RSV in Cardiovascular Diseases, Cancers and Degenerative Pathologies
Current Pharmaceutical Biotechnology N-Phenylamine Derivatives as Aggregation Inhibitors in Cell Models of Tauopathy
Current Alzheimer Research Radioimmunotherapy of Solid Tumors: Searching for the Right Target
Current Drug Delivery Protein Kinases and their Modulation in the Central Nervous System
Current Medicinal Chemistry - Central Nervous System Agents Phenylbutyric Acid: Simple Structure - Multiple Effects
Current Pharmaceutical Design